Literature DB >> 33245416

Suppression of miR-4463 promotes phenotypic switching in VSMCs treated with Ox-LDL.

Xueqin Wang1,2, Hui Li3, Yuetian Zhang1, Qi Liu4, Xiaolei Sun5, Xuemei He6, Qian Yang7, Ping Yuan8, Xiangyu Zhou9.   

Abstract

Vascular smooth muscle cell (VSMC) phenotypic switching is a hallmark of vascular remodeling that contributes to atherosclerotic diseases. MicroRNA 4463 (miR-4463) has been implicated in the development of arteriosclerosis obliterans, whereas the underlying mechanisms in VSMCs have not been fully addressed. In this study, we assessed whether miR-4463 is involved in the phenotypic switching process in VSMCs. Oxidized low-density lipoprotein (Ox-LDL, 50 mg/L) was used to simulate the oxidative stress condition, and miR-4463 expression in VSMCs was detected by a quantitative polymerase chain reaction. To determine the effect of Ox-LDL-mediated regulation of miR-4463 on the phenotypic switching of VSMCs, cell counting kit-8, cell migration assays, and cytoskeleton test were performed. After using specific antagonists of c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK), the relationship between miR-4463 and its downstream signaling proteins was explored. Ox-LDL induced oxidative stress to promote VSMC transformation from contraction to secretion, which clearly decreased the level of miR-4463. Then, downregulated miR-4463 enhanced the migration and phenotypic transformation of VSMCs and activated the phosphorylation of JNK and ERK; these effects were increased after Ox-LDL induction. As expected, inhibiting the two signaling proteins blocked the effect of the miR-4463 inhibitor combined with Ox-LDL. In addition, inhibition of miR-4463 led to the upregulation of basic fibroblast growth factor (bFGF) expression. The results of this study demonstrate that miR-4463 is a novel regulator of VSMC function in hypoxic conditions and modulates VSMC phenotypic switching via the JNK and ERK signaling pathways; bFGF may be the target gene of miR-4463.

Entities:  

Keywords:  Migration; Ox-LDL; Phenotypic switching; VSMC; miR-4463

Year:  2020        PMID: 33245416     DOI: 10.1007/s00441-020-03338-y

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  3 in total

1.  SIRT7 Regulates the Vascular Smooth Muscle Cells Proliferation and Migration via Wnt/β-Catenin Signaling Pathway.

Authors:  Jianghua Zheng; Kai Chen; Haifei Wang; Zhilong Chen; Yong Xi; Hongshun Yin; Kun Lai; Yujuan Liu
Journal:  Biomed Res Int       Date:  2018-12-04       Impact factor: 3.411

2.  Baicalin inhibits proliferation and promotes apoptosis of vascular smooth muscle cells by regulating the MEG3/p53 pathway following treatment with ox‑LDL.

Authors:  Yun Liu; Lianqun Jia; Dongyu Min; Yi Xu; Jinquan Zhu; Zengxian Sun
Journal:  Int J Mol Med       Date:  2018-11-30       Impact factor: 4.101

Review 3.  Impact of miRNA in Atherosclerosis.

Authors:  Yao Lu; Tanuja Thavarajah; Wenduo Gu; Jingjing Cai; Qingbo Xu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

  3 in total
  3 in total

1.  Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis.

Authors:  Jingquan Chen; Kun Lai; Xi Yong; Hongshun Yin; Zhilong Chen; Haifei Wang; Kai Chen; Jianghua Zheng
Journal:  Cardiovasc Drugs Ther       Date:  2022-06-15       Impact factor: 3.727

2.  17β-Estradiol Inhibits Proliferation and Oxidative Stress in Vascular Smooth Muscle Cells by Upregulating BHLHE40 Expression.

Authors:  Dan-Dan Feng; Bin Zheng; Jing Yu; Man-Li Zhang; Ying Ma; Xiao Hao; Jin-Kun Wen; Xin-Hua Zhang
Journal:  Front Cardiovasc Med       Date:  2021-11-30

3.  Curcumin-mediated Photodynamic Therapy Inhibits the Phenotypic Transformation, Migration, and Foaming of Oxidized Low-density Lipoprotein-treated Vascular Smooth Muscle Cells by Promoting Autophagy.

Authors:  Gailan Wang; Ying Zhu; Kaiting Li; Bo Liao; Fang Wang; Lan Shao; Liyi Huang; Dingqun Bai
Journal:  J Cardiovasc Pharmacol       Date:  2021-06-02       Impact factor: 3.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.